(주)넥소바이오
(주)넥소바이오's KOBDi Score is 47.97 as of Sep 2026, down 1.13 points since Apr 2025; it rose in 5 and fell in 2 of the 12 monthly updates. As of Sep 2026 it is ahead of about 58% of companies in its industry, against 58% in Aug 2026 and 34% in Apr 2025. Its strongest position was 62% (May 2026) and its weakest 34% (Aug 2025).
A year earlier, in Aug 2025, its score was 47.88 and it was ahead of about 34% of companies in its industry.
| Sep 2026 | 47.97 | ahead of 58% |
| Aug 2026 | 47.91 | ahead of 58% |
| Jul 2026 | 47.91 | ahead of 58% |
| Jun 2026 | 47.75 | ahead of 58% |
| May 2026 | 51.48 | ahead of 62% |
| Apr 2026 | 49.32 | ahead of 60% |
| Mar 2026 | 49.32 | ahead of 60% |
| Feb 2026 | 47.88 | ahead of 58% |
| Dec 2025 | 47.88 | ahead of 58% |
| Aug 2025 | 47.88 | ahead of 34% |
| Jul 2025 | 47.82 | ahead of 34% |
| May 2025 | 49.11 | ahead of 35% |
| Apr 2025 | 49.10 | ahead of 34% |
Where is (주)넥소바이오 located?
(주)넥소바이오 is registered at 충북 청주시 흥덕구 봉명로, South Korea (postal code 28589).
What industry is (주)넥소바이오 in?
(주)넥소바이오 belongs to Manufacturing › Pharmaceuticals & Biologics › Manufacturing of medical supplies and other medicine-related products.
How many employees does (주)넥소바이오 have?
(주)넥소바이오 has 5–9 employees.
What is (주)넥소바이오's KOBDi Score?
47.97 as of September 2026, ahead of about 58% of companies in its industry.
Who are (주)넥소바이오's competitors?
Similar companies include CYM INSTRUMENT, PARK YOUNG HOON and (주)바디코스.

